Fibroids & Reproductive Function

David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.

A new SFP Committee Statement in Contraception standardizes protocols for removing deep and nonpalpable contraceptive implants.

Atogepant reduced perimenstrual migraine days vs. placebo and met all 8 secondary endpoints in the Phase 3 LUNA study.

A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.

David Shalowitz, MD, MSHP, describes how OB-GYNs can collaborate with non-gynecologic surgeons to extend salpingectomy and reduce ovarian cancer risk during other abdominal procedures.

David Shalowitz, MD, MSHP, explains that stronger effectiveness and safety data in average-risk patients drove ACOG's strengthened salpingectomy recommendation.

A recap of the top stories from August 2026 in women's health.

Take a look back at some of the top FDA and pipeline news in women's health from August 2026.